Simian immunodeficiency virus (SIV) isolated from sooty mangabeys (SIVsmm) or macaques (SIVmac) induces an immunodeficiency syndrome in infected macaques that is similar to human AIDS. Experimental infection in macaques is characterized by a progressive loss of circulating CD4 lymphocytes and infections due to opportunistic agents such as mycobacteria, cytomegalovirus, and pneumocystis (1, 7, 25, 28, 38) . Additional similarities to human AIDS include a wasting syndrome and central nervous system disease that may result from direct SIV invasion (1, 8, 25, 27, 38) . These similarities make the SIV/macaque model ideal for the study of AIDS pathogenesis. The disease associated with SIV and human immunodeficiency virus type 1 (HIV-1), like that of other lentiviruses, is generally slow, progressive, and chronic. However, similar to many other viral infections, HIV-1 infection also induces an acute viral syndrome during a period prior to seroconversion, coinciding with peak antigenemia and viremia (34) (35) (36) . Symptoms observed include fever, malaise, flu-like symptoms, rash, diarrhea, meningitis, lymphadenopathy, and oral thrush (34) (35) (36) . Patients then enter an asymptomatic phase of infection that is variable in duration. The acute phase of SIV infection of macaques has not been intensively studied; however, SIVinfected macaques develop antigenemia, rash, and lymphadenopathy within 2 weeks of infection, suggesting a comparable acute syndrome (25, 38) . The macaques is apparently self-limiting, and the symptoms are generally not severe.
One SIVsmm strain (PBj14) induces an acutely lethal syndrome following intravenous inoculation of pig-tailed macaques (Macaca nemestrina). This strain was isolated from peripheral blood mononuclear cells (PBMC) of a pigtailed macaque (PBj) that was chronically infected with the SIVsmm9 strain for 14 months (14) . Whereas infection of macaques with the parental SIVsmm9 resulted in immunodeficiency (13, 28) , this new isolate consistently caused severe diarrhea, acidosis, and volume depletion, culminating in death of inoculated pig-tailed macaques within 5 to 14 days after infection (14, 26, 37) . In addition to having altered pathogenesis, SIVsmmPBj (PBj), unlike other SIVsm and SIVmac isolates, infects chimpanzee PBMC and mitogenically stimulates resting macaque PBMC (13, 14) . Recently, molecular clones that reproduce the lethal syndrome (PBj4.41, PBj1.9, and PBj4.9 [9] ) were generated. Sequence analysis of PBj and comparison with other SIVsm molecular clones revealed minor differences in the envelope, primarily within the first variable region, and duplication of an enhancer element, the NF-KB motif within the long terminal repeat (LTR) (9) . The same duplication was also observed in LTRs of PBj derived by the polymerase chain reaction (PCR) in two other studies (6, 31) , whereas the LTRs of the parental SIVsmm9 had a single NF-KB element (6) . Since NF-KB is an important regulatory element controlling HIV-1 transcription in activated lymphocytes (15) nemestnina) and sooty mangabey (Cercocebus atys) PBMC were obtained by density centrifugation in lymphocyte separation medium (Organon Teknika Corp., Durham, N.C.) and cultured in RPMI 1640 supplemented with 10% fetal bovine serum, 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.0), glutamine, 10 ,ug of phytohemaglutinin (PHA) per ml, and 1% interleukin-2 for the first 4 days. Macaque and mangabey PBMC were infected by incubating cells with cell-free virus for 2 h at 37°C with intermittent mixing. At the end of the adsorption period, cells were washed and resuspended in medium as described above without PHA, and the culture supernatant was monitored for reverse transcriptase activity.
Cloning strategy. Genomic DNA prepared from PBjbcl3-infected CEMx174 cells was used as the template for PCR amplification of SIV-specific sequences as described previously (30, 31) . The strategy for producing full-length molecular clones by generating 5' and 3' halves using PCR and then combining them has previously been described in detail (9, 31) . Primers for amplification of 5' and 3' halves of PBjbcl3 were synthesized on an Applied Biosystems 380B DNA synthesizer (Applied Biosystem, Inc., Foster City, Calif.) and were derived from the smH4 nucleotide sequence (18) . For shown at the top; white boxes represent smH4, and black boxes represent PBj6.6. The constructions of the chimeric clones are shown below with relevant restriction sites. These schematics are representative of the genetic composition of the molecular clones, not of the viral RNA that would result from transfection into susceptible cell lines. As a result of reverse transcription, the RNA genome that would result from 5'smH4/3'PBj6 and 5'PBj6/3'smH4 would contain R and U5 at the 5' end and U3 and R at the 3' end; the U3 and R regions would be derived from the 3' LTR, and US would be derived from the 5' LTR, of the transfected clones. (B) Inverse PCR technique to introduce an NdeI site into PBj6.6. Oligonucleotide primers 1608 and 1607 (see Materials and Methods) were used to amplify a linear copy of the ClaI-XhoI subclone of PBj6.6. The resulting PCR fragment was treated with T4 DNA kinase and then with T4 DNA polymerase, ligated to recircularize, and transformed into E. coli. The resulting clones were screened for introduction of the unique NdeI site, and the sequence was determined in its entirety.
A mean was derived for each triplicate set, and a stimulation index (SI) was calculated for each concentration of virus.
Nucleotide sequence accession number. The nucleotide sequences of PBj clones PBj6.6, PBj6.9, and PBj6.12 have been submitted to GenBank under accession numbers L09212, L09213, and L09211, respectively.
RESULTS
Generation of infectious molecular clones of PBj. Genomic DNA isolated from the biological clone of PBj (PBjbcl3) was used as a template for PCR amplification of 5' and 3' segments of the PBj genome. Two 5' genome halves (5'6 and 5 '14) and three 3' genomes (3'6, 3'9, and 3'12) were generated, and six full-length molecular clones were thus derived. These clones were designated according to the numbers of the 5' and 3' halves used to generate the clone. For example, clone PBj6.9 was constructed from 5'PBj6 and 3'PBj9. All clones were infectious, as determined by transfection into CEMx174 cells; pronounced cytopathic effects were evident by 2 days after transfection. Similar to the parental virus, all six viruses replicated efficiently in CEMx174 cells, pig-tailed macaque PBMC, and mangabey PBMC.
A molecular clone of PBj that reproduces the acute disease. Each viral stock was inoculated into two pig-tailed macaques. The infectious titers of these viral stocks were similar with the exception of PBj14.9, for which the in vitro infectious titer was about 10-fold lower. Macaques inoculated with PBj clones sharing the 3'PBj6 sequences (PBj6.6 and PBj 14.6) developed the acute lethal syndrome. Severe diarrhea accompanied by dehydration, lethargy, rash, fever, and severe lymphopenia (a mean of 972/,ul) were observed and necessitated humane sacrifice of these four macaques by 7 days postinoculation. Virus could be isolated from PBMC by 3 days postinoculation, and high levels of viral antigen, as (6, 9) . A series of PBj6.6/smH4 molecular chimeras was therefore constructed by exchanging three regions of the viral genome: (i) the 5' and 3' segments, (ii) the LTRs, and (iii) envelope genes.
The 5' and 3' segments were exchanged by using a conserved BclI site within the terminal end of vif, as shown in Fig. 1 . A conserved NarI site within the primer binding site was used to exchange the LTR regions, in addition to an NdeI site in near the C terminus of the envelope gene (and N terminus of the nef gene) of smH4. The PBj6.6 clone lacked this NdeI site as a result of a single base substitution relative to smH4; thus, an NdeI site was introduced into PBj6.6 by PCR mutagenesis (Fig. iB) . Four errors were introduced in the resulting clone presumably as a result of Taq polymerase; the resulting changes in amino acid sequence of Env and Nef are detailed in Table 3 . Finally, the envelope genes were similarly exchanged by using a conserved BsmI site in the amino terminus of env and the NdeI site described above to generate two clones (smH4/PBj env and PBj6.6/smH4 env). Envelope genes were not exchanged precisely as a result of the positions of the BsmI site, 16 Pathogenicity of progeny virions of these six chimeras was tested by intravenous inoculation of two macaques per construct. The reconstructed PBj clone with the engineered NdeI site (PBj6.6 Nde+) was included as a positive control to verify that nucleotide substitutions introduced during PCR mutagenesis had not altered its pathogenicity. As shown in Table 4 , despite the PCR errors in PBj6.6 Nde+, this virus maintained the lethal phenotype.
Macaques inoculated with each of the chimeras became persistently viremic with the exception of PBo, an animal inoculated with a chimera containing the smH4 genome with PBj6.6 LTRs. This animal has shown no evidence of SIV infection by virus isolation, Western immunoblot analysis, and PCR amplification from PBMC. Only virus derived from a clone that expressed the entire PBj genome under the control of the smH4 LTRs induced acute disease. One of the two macaques inoculated with this chimera developed typical fulminant PBj disease. Lethargy, rash, and lymphopenia were the only signs observed in the other macaque of this pair. Plasma from either of these macaques contained p27 viral antigen; however, the level of antigenemia was much higher in the macaque that succumbed to disease ( Table 4) . As observed previously, macaques sacrificed with acute disease had high levels of viral antigen in their plasma at 7 days; an apparent exception was a macaque inoculated with of the PBj envelope for that of smH4 eliminated the acutely pathogenic phenotype. In contrast, the duplicated NF-KB motif within the PBj LTR does not appear to be a critical disease determinant; a chimera in which the PBj LTR was replaced with an smH4 LTR was still capable of inducing full expression of the acute disease in 50% of inoculated macaques. Further inoculations would be required to determine whether this chimera is somewhat attenuated with respect to wild-type PBj.
Mitogenic activity of PBj as an in vitro correlate of pathogenicity. The results of macaque inoculations with chimeric viruses suggested the involvement in multiple genes in pathogenicity. An in vitro assay to screen candidate constructs would minimize the number of macaques required for in vivo studies. PBj has a number of unique biologic properties, such as the ability to stimulate proliferation of macaque PBMC and the ability to infect chimpanzee PBMC, that could be used as in vitro correlates of pathogenicity. Since the ability to stimulate proliferation of resting macaque PBMC could be a potential basis for the acute disease induced by PBj, the PBj viruses and chimeras generated in this study were analyzed for their effects on PBMC of an uninfected pig-tailed macaque. The mitogenic effects of virus supernatants derived from CEMx174 cell transfections were assessed after incubation of resting macaque PBMC with different concentrations of SIV p27 (Table 5 ). Triplicate wells were assessed for thymidine incorporation, a mean was derived for each virus, and thymidine incorporation was compared with that in a medium-alone control to derive an SI for each virus (Fig. 2) . Incubation of the acutely pathogenic PBj6.6 virus resulted in a significant proliferative response (SI of 80), whereas incubation with smH4 did not induce a proliferative response (SI of 3.8). As shown in Fig.  2 , the three viruses that induced the characteristic PBj disease (PBj6.6, PBj14.6, and PBj6.6 Nde+) induced proliferation of macaque PBMC in this assay, whereas those that did not induce disease induced minimal to no proliferation. A few of the virus supernatants induced a moderate degree of proliferation, with SIs of 10 to 15 with 1 ng of the viral antigen. Interestingly, these viruses, PBj6.9, PBj6.12, 5'PBj6/3'smH4, and PBj6.6/smH4 LTR, included the latter chimera, which induced 50% mortality of inoculated macaques. A gradation of intermediate effects was observed with this assay, and no single gene was associated with the mitogenic property. The general correlation of mitogenic effect with pathogenicity suggests that the underlying pathogenesis of acute PBj disease is linked to the ability of PBj to stimulate resting PBMC in vivo.
DISCUSSION
Six infectious molecular clones of the SIVsmm variant PBj were generated, and their pathogenicity for pig-tailed macaques was evaluated. Two clones induced the acutely lethal disease in inoculated pig-tailed macaques. In contrast to the genetic heterogeneity of clones derived in a preliminary study in which the virus isolate used for cloning was derived from a terminally ill PBj-infected macaque (PGg) (31), the clones used in this study were similar in sequence to one another and to PBj4.41 (9) . Despite this genetic homogeneity, only two of the six clones induced the acute disease syndrome in experimentally inoculated pig-tailed macaques. Fine genetic differences (amino acid substitutions and deletions) in vpx, env, the LTR, and nef were observed among these clones. Substitutions in nef were also shared with the lethal PBj4.41 clone; hence, nef is unlikely to be critical gene responsible for the differing pathogenicity of these clones. (19) . Preliminary studies have investigated a potential role for superantigens in HIV-1 infection, but so far these studies have been inconclusive (20, 23) . Distinguishing between these possible mechanisms of PBj-induced proliferation is beyond the scope of this study. More detailed studies of the in vitro effects of PBj on PBMC will be necessary to address this issue. Since the in vitro effect correlates with pathogenicity, a better understanding of PBj-induced proliferation may aid in delineating the pathogenic mechanism of PBjinduced gastroenteritis.
The disease syndrome induce by PBj is not unlike the acute phase of HIV infection in humans. Thus, as in the acute viral syndrome observed in humans shortly after infection by HIV-1, PBj-infected macaques develop a fever, rash, lymphadenopathy, lymphopenia, and diarrhea (26, (34) (35) (36) (37) . However, whereas the acute phase of HIV infection is a transient nonlethal syndrome, the symptoms of PBjinduced disease are rapid, severe, and life threatening. Since PBj induces proliferation of resting macaque PBMC in culture, it is feasible that a similar effect in the infected animal results in widespread activation of lymphocytes/ monocytes and the concurrent release of cytokines such as tumor necrosis factor ot and interleukin-6. Indeed, the pathologic features of PBj-induced gastroenteritis, diffuse infiltration of SIV-infected lymphoid cells into the lamina propria of the intestinal tract with blunting of villi, are consistent with a cytokine-mediated enteritis (26, 27, 37) . Lymphocyte activation would amplify the number of cellular targets for virus infection and allow rapid dissemination of virus throughout the lymphoid system, as suggested by the early plasmaassociated viremia (7 days postinoculation) observed in PBj-infected macaques. Further molecular, virologic, and pathologic studies will be necessary to more clearly define the events that lead to the rapid death of these macaques, the viral genes responsible, and the critical interactions with the immune system of their host.
